Point72 Hong Kong LTD Harpoon Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $2,526 - $3,476	-444 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.88 - $14.0 $9,195 - $16,338	-1,167 Reduced 72.44%	444 $4,000
Q2 2021 Aug 16, 2021	BUY	$13.81 - $23.25 $22,247 - $37,455	1,611 New	1,611 $22,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $953 - $1,304	-54 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $692 - $963	54 New	54 $1,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.